MSH|^~\&|^2.16.840.1.113883.3.72.5.20^ISO|^2.16.840.1.113883.3.72.5.21^ISO||^2.16.840.1.113883.3.72.5.23^ISO|20150926140551||ORU^R01^ORU_R01|LRI_5.1_1.1-GU_FRN|D|2.5.1|||AL|AL|||||LRI_Common_Component^^2.16.840.1.113883.9.16^ISO~LRI_GU_Component^^2.16.840.1.113883.9.12^ISO~LAB_FRN_Component^^2.16.840.1.113883.9.84^ISOPID|1||PATID1239^^^&2.16.840.1.113883.3.72.5.30.2&ISO^MR||Smirnoff^Peggy^^^^^L||19750401|F||2106-3^White^HL70005||||||||PATID1239^^^&2.16.840.1.113883.3.72.5.30.2&ISO^ANORC|RE|ORD448811^^2.16.840.1.113883.3.72.5.24^ISO|R-511^^2.16.840.1.113883.3.72.5.25^ISO|||||||||5742200012^Radon^Nicholas^^^DR^^^&2.16.840.1.113883.4.6&ISO^L^^^NPIOBR|1|ORD448811^^2.16.840.1.113883.3.72.5.24^ISO|R-511^^2.16.840.1.113883.3.72.5.25^ISO|HepABC Panel^Hepatitis A B C Panel^L|||20150925|||||||||5742200012^Radon^Nicholas^^^DR^^^&2.16.840.1.113883.4.6&ISO^L^^^NPI||||||20150926140500-0800|||FOBX|1|CWE|22314-9^Hepatitis A virus IgM Ab [Presence] in Serum^LN^HAVM^Hepatitis A IgM antibodies (IgM anti-HAV)^L^2.52||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^201509USEd^^Negative (qualifier value)||Negative|N|||F|||20150925|||||201509261400||||Century Hospital^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^90067^USA^B^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLTOBX|2|CWE|20575-7^Hepatitis A virus Ab [Presence] in Serum^LN^HAVAB^Hepatitis A antibodies (anti-HAV)^L^2.52||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^201509USEd^^Negative (qualifier value)||Negative|N|||F|||20150925|||||201509261400||||Century Hospital^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^90067^USA^B^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLTOBX|3|CWE|16933-4^Hepatitis B virus core Ab [Presence] in Serum^LN^HBVcAB^Hepatitis B core antibodies (anti-HBVc)^L^2.52||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^201509USEd^^Negative (qualifier value)||Negative|N|||F|||20150925|||||201509261400||||Century Hospital^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^90067^USA^B^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLTOBX|4|SN|22316-4^Hepatitis B virus core Ab [Units/volume] in Serum^LN^HBcAbQ^Hepatitis B core antibodies (anti-HBVc) Quant^L^2.52||^0.40|[IU]/mL^international unit per milliliter^UCUM^IU/ml^^L^1.9|<0.50 IU/mL|N|||F|||20150925|||||201509261400||||Century Hospital^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^90067^USA^B^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLTOBX|5|CWE|22320-6^Hepatitis B virus e Ab [Presence] in Serum^LN^HBVeAB^Hepatitis B e antibodies (anti-HBVe)^L^2.52||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^201509USEd^^Negative (qualifier value)||Negative|N|||F|||20150925|||||201509261400||||Century Hospital^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^90067^USA^B^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLTOBX|6|CWE|5195-3^Hepatitis B virus surface Ag [Presence] in Serum^LN^HBVsAG^Hepatitis B surface antigen (HBsAg)^L^2.52||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^201509USEd^^Negative (qualifier value)||Negative|N|||F|||20150925|||||201509261400||||Century Hospital^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^90067^USA^B^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLTOBX|7|CWE|22322-2^Hepatitis B virus surface Ab [Presence] in Serum^LN^HBVSAB^Hepatitis B surface antibody (anti-HBVs)^L^2.52||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^201509USEd^^Negative (qualifier value)||Negative|N|||F|||20150925|||||201509261400||||Century Hospital^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^90067^USA^B^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLTOBX|8|CWE|16128-1^Hepatitis C virus Ab [Presence] in Serum^LN^HCVAB^Hepatitis C antibody screen  (anti-HCV)^L^2.52||10828004^Positive (qualifier value)^SCT^POS^POSITIVE^L^201509USEd^^Positive (qualifier value)||Negative|A|||F|||20150925|||||201509261400||||Century Hospital^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^90067^USA^B^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLTOBX|9|SN|48159-8^Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay^LN^HCVSCO^Hepatitis C antibodies Signal to Cut-off Ratio^L^2.52||^10.8|{s_co_ratio}^Signal to cutoff ratio^UCUM^s/co^^L^1.9|0.0-0.9 s/co|H|||F|||20150925|||||201509261400||||Century Hospital^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^90067^USA^B^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLTNTE|1||Negative:   < 0.8; Indeterminate 0.8 - 0.9; Positive:  > 0.9NTE|2||In order to reduce the incidence of a false positive result, the CDC recommends that all s/co ratios between 1.0 and 10.9 be confirmed with additional Verification or PCR testing.SPM|1|S-2015-666666&&2.16.840.1.113883.3.72.5.24&ISO^S-991133&&2.16.840.1.113883.3.72.5.25&ISO||119364003^Serum specimen (specimen)^SCT^SER^Serum^L^201509USEd|||||||||||||20150925